From 15 h, the levels of caspase 3/7 activation were significantly higher in the iPSC-derived motor neurons from the SOD1E101G MND patient treated with ephrin A4-Fc compared to motor neurons without treatment (Figure 3). This evidence concerns the gene CASP3 and mild neurocognitive disorder.